NIH-funded research NIH-funded research

Investigating emerging infectious diseases and developing medical countermeasures.

Official title: Pitt RBL

Funded at University of Pittsburgh at Pittsburgh · NIH-10910178 · Data updated 2026-11-12

This study at the University of Pittsburgh is looking into how germs spread and cause illness, with the goal of creating better treatments and vaccines to help keep everyone safe during outbreaks and health emergencies.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startAugust 18, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$2,594,826
NIH project number5UC7AI180311-02
Project IDNIH-10910178 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit include individuals at risk for emerging infectious diseases or those involved in healthcare and public health.

Less likely to help

Patients with established chronic conditions unrelated to infectious diseases may not receive direct benefits from this research.

What this research studies

The Regional Biocontainment Laboratory at the University of Pittsburgh focuses on understanding how infectious diseases emerge and spread between hosts. This research involves studying the biology of pathogens and their interactions with hosts to develop new medical interventions and countermeasures. Patients may benefit from advancements in treatments and vaccines that arise from this work, particularly in response to pandemics and biological threats. The laboratory collaborates with various disciplines to ensure a comprehensive approach to infection biology.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective treatments and vaccines for emerging infectious diseases.

How similar studies have gone: Previous research in similar biocontainment settings has shown success in developing vaccines and treatments for infectious diseases.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Duprex, William Paul — University of Pittsburgh at Pittsburgh
  • Study coordinator: Duprex, William Paul

Related research

Other NIH-funded projects on the same topics.

  • Elastomeric membranes for safer pelvic organ prolapse repair

    A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668074

  • Role of hyaluronan in egg development and ovarian reserve

    This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668041

  • Regulatory switches that control imprinting in early human development

    This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11668004

  • Identifying molecular signs of imprinting errors linked to fertility treatments

    This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11667742

  • Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy

    A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11645331

  • Spermatogonial stem cell transplantation and culture in patients

    Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11645297

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.